Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2012
06/20/2012EP2464369A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
06/20/2012EP2198026B1 Hepatitis b pre-s2 nucleic acid
06/20/2012EP2129799B1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same
06/20/2012EP2073829B1 Stabilized therapeutic small helical antiviral peptides
06/20/2012EP1866331B1 Methods and means for determining and conferring stress tolerance in plants
06/20/2012EP1799711B1 Protracted exendin-4 compounds
06/20/2012EP1699821B1 Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS
06/20/2012EP1691837B1 Ip-10 antibodies and their uses
06/20/2012EP1563061B1 Cultivation of hair inductive cells
06/20/2012EP1534738B1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
06/20/2012EP1527080B1 Campylobacter glycans and glycopeptides
06/20/2012EP1487479B1 Mutant glycoproteins
06/20/2012EP1463942B2 Methods for purifying protein
06/20/2012EP1452541B1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
06/20/2012EP1252182B1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
06/20/2012EP1240315B1 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof
06/20/2012EP1071825B1 Method for typing of hla alleles
06/20/2012CN1942201B Methods of modulating cytokine activity, related reagents
06/20/2012CN102505016A Transmembrane protein gene triticum asetivum leucine rich repeat 3 (TaLRR3) with leucine rich repeat (LRR) structure domain as well as expression vector and application thereof
06/20/2012CN102505015A Gene sequence of plant antifreeze protein, encoding protein and application thereof
06/20/2012CN102504572A Synthesis methods of sunset yellow hapten and artificial antigen
06/20/2012CN102504025A Estrogen receptors and methods of use
06/20/2012CN102504022A Proinsulin containing protecting lysine and preparation method for insulin by utilizing proinsulin
06/20/2012CN102504021A FBXL15 protein as well as inhibitor of FBXL15 protein and applications of FBXL15 protein and inhibitor
06/20/2012CN102504020A Polypeptide capable of inducing antibody against chicken beta2-microglobulin and use thereof
06/20/2012CN102504019A Method for separating cecropin antimicrobial peptides
06/20/2012CN102504018A Melittin pamoate capable of being continuously released and preparation agent thereof
06/20/2012CN102504017A Novel Enterococcus and Streptococcus strains and bacteriocins
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN102504002A Progesterone artificial antigen, preparation method for same and application thereof
06/20/2012CN101899109B Synthesis method of 4-amino azobenzene artificial antigen
06/20/2012CN101838628B Method for producing L-amino acids using bacteria belonging to the genus escherichia
06/20/2012CN101684151B Protein matter with coagulation activity
06/20/2012CN101643501B Novel antibiotic and nucleotide sequence, preparation method and application thereof
06/20/2012CN101333250B Plant stress related protein MASTER applications thereof for encoding gene
06/20/2012CN101255419B P ef-tu expression units
06/20/2012CN101223190B Production of insulin bonder
06/20/2012CN101072793B Il-7 variants with reduced immunogenicity
06/19/2012US8202969 Platelet derived growth factor receptor alpha (PDGFRA) polypeptides comprising activating mutation(s)
06/19/2012US8202968 Predicting lung cancer survival using gene expression
06/19/2012US8202966 Human Dickkopf-related protein and nucleic acid molecules and uses therefor
06/19/2012US8202847 Mutant human CD80 and compositions for and methods of making and using the same
06/19/2012US8202836 Modified PYY (3-36) peptides and their effects on feeding behavior
06/19/2012US8202704 Trichoderma genes
06/19/2012US8202700 Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
06/19/2012US8202699 Use of biological photoreceptors as directly light-activated ion channels
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2474108C Novel fluorescent proteins from aequorea coerulscens and methods for using same
06/19/2012CA2406169C Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/19/2012CA2406104C System for functional gene discovery in plants
06/19/2012CA2405721C Transcription factor stress-related proteins and methods of use in plants
06/19/2012CA2405703C Cell cycle stress-related proteins and methods of use in plants
06/19/2012CA2405697C Phosphatase stress-related proteins and methods of use in plants
06/19/2012CA2400534C A dominant selectable marker for gene transformation and disruption in yeasts
06/19/2012CA2393975C Insect poison allergens with reduced ige reactivity and method for producing the same
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/19/2012CA2314610C Method for preparing by filtration a virally secure factor viii solution
06/19/2012CA2312976C Compositions comprising histidine-linked protein polymer conjugates
06/19/2012CA2311166C Nucleic acids involved in the responder phenotype and applications thereof
06/19/2012CA2256125C Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, useful for serologic diagnosis of canine leishmaniasis and protein obtained
06/19/2012CA2241726C Genes and gene products related to werner's syndrome
06/14/2012WO2012079088A2 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
06/14/2012WO2012078936A2 Methods to produce a purified peptide chain fraction
06/14/2012WO2012078850A2 Hemoglobin compositions and methods of use
06/14/2012WO2012078313A2 Gb1 peptidic libraries and compounds, and methods of screening the same
06/14/2012WO2012078116A1 Immunogenic chikungunya virus peptides
06/14/2012WO2012078069A1 Spherical nano- and microparticles derived from plant viruses for the display of foreign proteins or epitopes
06/14/2012WO2012077849A1 Antimicrobial peptide multiblock copolymer to be expressed on surface of cells
06/14/2012WO2012077078A1 Modified protein body tags and production methods thereof
06/14/2012WO2012077037A2 PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2
06/14/2012WO2012076846A1 Polymorphism
06/14/2012WO2012076722A1 Biomarkers for the diagnosis of multiple sclerosis
06/14/2012WO2012076708A1 Immune restricted peptides with increased efficacy
06/14/2012WO2012076668A1 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
06/14/2012WO2012076059A1 Immune restricted peptides with increased efficacy
06/14/2012WO2012075911A1 Use of recombinant human prx-6 protein in treatment of burn and scald and/or corneal injury
06/14/2012WO2012050930A3 Engineered polypeptides having enhanced duration of action
06/14/2012WO2012050714A3 Cartilage oligomeric matrix protein (comp)-growth factor complexes and uses thereof
06/14/2012WO2012049307A3 Novel n-terminally modified insulin derivatives
06/14/2012WO2012049179A3 Polypeptides with kinase activity
06/14/2012WO2012049170A3 Pentose and glucose fermenting yeast cell
06/14/2012WO2012047930A3 Compositions and methods for treatment of gynecologic cancers
06/14/2012WO2012035050A3 Factor viii variants having a decreased cellular uptake
06/14/2012WO2012007945A3 Isolated polynucleotides and methods and plants using same for regulating plant acidity
06/14/2012WO2011163531A3 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
06/14/2012WO2011140135A9 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
06/14/2012WO2011139385A3 Genetic signatures in hiv-1 subtype c envelope glycoproteins
06/14/2012WO2011134979A3 Stable aqueous mia/cd-rap formulations
06/14/2012WO2011063990A8 Spider silk particles for controlled and sustained delivery of compounds
06/14/2012WO2011056060A8 Recombinant matrix protein of nipah virus
06/14/2012WO2011027129A9 Treatment of vasculoproliferative conditions
06/14/2012WO2008014521A8 Improved vaccines and methods for using the same
06/14/2012US20120151630 Methods and materials for making and using transgenic dicamba-degrading organisms
06/14/2012US20120149874 Method for preparing recombinant glycoproteins with high sialic acid content
06/14/2012US20120149871 Synthetic, Defined Fibronectin Mimetic Peptides And Surfaces Modified With The Same
06/14/2012US20120149870 Sequentially arranged streptavidin-binding modules as affinity tags
06/14/2012US20120149869 Alpha-conotoxin peptides
06/14/2012US20120149868 Purification of peptides prepared by solid phase synthesis
06/14/2012US20120149867 Method For Processing Crustaceans And Products Thereof
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 ... 2916